Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-30
1998-03-31
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514391, 514395, A61K 3152, A61K 31415
Patent
active
057339155
ABSTRACT:
A therapeutic method for the treatment of Crohn's disease is provided, comprising administering to a patient in need of said treatment an intravenous dose of azathioprine or a pharmaceutically acceptable derivative thereof.
REFERENCES:
patent: 3056785 (1962-10-01), Hitchings et al.
P.C. Adamson et al., "A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors", Cancer Chemother. Pharmacol., 26, 343-344 (1990).
C.A.S. Arndt et al., "Bioavailability of low-dose vs. high-dose 6-mercaptopurine", Clin. Pharmacol. Ther., 43, 588-591 (May 1988).
G.L.C. Chan et al., "Azathioprine Metabolism: Pharmacokinetics of 6-Mercaptopurine, 6-Thiouric Acid and 6-Thioguanine Mucleotides in Renal Transplant Patients", J. Clin. Pharmacol., 30, 358-363 (1990).
W.R. Connell et al., "Bone Marrow Toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience", Gut, 34, 1081-1085 (1993).
A.B. Hawthorne et al., "Randomised controlled trial of azathioprine withdrawal in ulcerated colitis", Brit. J. Med., 305, 20-22 (1992).
M. Klein et al., "Treatment of Crohn's Disease with Azathioprine: A Controlled Evaulation", Gastroenterology, 66, 916-922 (1974).
B.I. Korelitz et al., "Shortcomings of the National Crohn's Disease Study: The Exclusion of Azathioprine Without Adequate Trial", Gastroenterology, 80, 193-194 (1981).
B.I. Korelitz et al., "Favorable Effect of 6-Mercaptopurine on Fistulae of Crohn's Disease", Digestive Diseases and Sciences, 30, 58-64 (Jan. 1985).
L. Lennard et al., "Azathioprine metabolims in kidney transplant recipients", Br. J. Clin. Pharmac., 18, 693-700 (1984).
J. Markowitz et al., "Long-Term 6-Mercaptopurine Treatment in Adolescents with Crohn's Disease", Gastroenterology, 99, 1347-1351 (1990).
M. Nyman et al., "Long-Term Immunosuppressive Treatment in Crohn's Disease", Canadian J. Gastroenterology, 20, 1197-1203 (Nov. 10, 1985).
B. Odlind et al., "Serum Azathioprine and 6-Mercaptopurine Levels and Immunosuppressive Acitivity after Azathioprine in Uremic Patients", Int. J. Immunopharmac., 8, 1-11 (1986).
D.P. O'Donoghue et al., "Double-Blind Withdrawal Trial of Azathioprine as Maintenance Treatment for Crohn's Disease", The Lancet, 955-957 (Nov. 4, 1978).
J. Perrault et al., "6-Mercaptopurine Therapy in Selected Cases of Corticosteroid-Dependent Crohn's Disease", Mayo Clin. Proc., 66, 480-484 (1994).
D.H. Present et al., "Treatment of Crohn's Disease with 6-Mercaptopurine", N. Eng. J. Med., 302, 981-987 (May 1, 1980).
D.H. Present et al., "6-Mercaptopurine in the Management of inflammatory Bowel Disease Short- and Long- Term Toxicity", Annals of Internal Medicine, 111, 641-649 (Oct. 15, 1989).
J. Rhodes et al., "Controlled Trial of Azathioprine in Crohn's Disease", The Lancet, 1273-1276 (Dec. 11, 1971).
J.L. Rosenberg et al., "A Controlled Trial of Azathioprine in Crohn's Disease", Digestive Diseases, 20, 721-726 (Aug. 1975).
J.W. Singleton, "Azathioprine Has a Very Limited Role in the Treatment of Crohn's Disease", Digestive Diseases and Sciences, 26, 368-371 (Apr. 1981).
R.W. Summers et al., "National Cooperative Crohn's Disease Study: Results of Drug Treatment", Gastroenterology, 77, 847-869 (1979).
M. Verhave et al., "Azathioprine in the treatment of children with inflammatory bowel disease", J. Pediatrics, 117, 809-814 (Nov. 1990).
J.M.T. Willoughby et al., "Controlled Trial of Azathioprine in Crohn's Disease", The Lancet, 944-946 (Oct. 30, 1971).
W.P. Wilson et al., "Azathioprine" in Analytical Profiles of Drug Substances, vol. 10; K. Florey, Ed.; Academic Press: New York; pp. 30-53; 1981.
S. Zimm et al., "Phase I and Clinical Pharmacological Study of Mercaptopurine Administered as Prolonged Intravenous Infusion", Cancer Research, 45, 1869-1873 (Apr. 1985).
S. Zimm et al., "Variable Bioavailability of Oral Mercaptopurine", N. Eng. J. Med., 308, 1005-1009 (1983).
Criares Theodore J.
Glaxo Wellcome Inc.
Hrubiec Robert T.
Woessner Warren D.
LandOfFree
Use of azathioprine to treat crohn's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of azathioprine to treat crohn's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of azathioprine to treat crohn's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52287